RSP:ARCA-Guggenheim S&P 500 Equal Weight

ETF | Others | NYSE Arca

Last Closing

USD 109.65

Change

-0.09 (-0.08)%

Market Cap

USD 10.83B

Volume

0.33M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to replicate as closely as possible, before fees and expenses, the daily performance of the S&P 500? Equal Weight Index Total Return. The fund invests primarily in equity securities to meet its investment objective of replicating the underlying index as closely as possible, before fees and expenses. The underlying index is an unmanaged equal weighted version of the S&P 500? Index, which is an unmanaged capitalization weighted index comprised of 500 common stocks chosen by Standard & Poor's, a Division of The McGraw-Hill Companies, Inc. ("S&P") on a statistical basis. The fund is non-diversified.

Inception Date: 24/04/2003

Primary Benchmark: S&P 500 Equal Weighted TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.4%

Management Expense Ratio: 0.20 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
SCPS Scopus Biopharma Inc 0.23 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
SOJE SOJE 0.00 %

+0.04 (+0.21%)

USD 65.72B
JEPI JPMorgan Equity Premium Income.. 0.00 %

-0.11 (-0.20%)

USD 32.78B
LCR Leuthold Core ETF 0.00 %

-0.09 (-0.27%)

USD 32.52B
DTB DTB 0.00 %

-0.12 (-0.63%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2.. 0.00 %

-0.03 (-0.10%)

USD 26.11B
JPST JPMorgan Ultra-Short Income ET.. 0.00 %

N/A

USD 22.47B
SGOV iShares® 0-3 Month Treasury B.. 0.00 %

+0.03 (+0.03%)

USD 18.58B
TSPA T. Rowe Price US Equity Resear.. 0.00 %

-0.07 (-0.22%)

USD 16.23B
DFUV Dimensional US Marketwide Valu.. 0.00 %

+0.04 (+0.10%)

USD 10.15B
AVUV Avantis® U.S. Small Cap Value.. 0.00 %

+0.02 (+0.02%)

USD 10.05B

ETFs Containing RSP

EVEN 78.47 % 0.00 %

N/A

N/A
SNAV 28.01 % 0.00 %

N/A

N/A
INAV 23.00 % 0.00 %

N/A

N/A
LEXI Alexis Practical Tactical.. 6.00 % 0.00 %

-0.09 (0%)

USD 0.08B
TBFG The Brinsmere Fund - Grow.. 3.14 % 0.00 %

-0.08 (0%)

USD 0.27B
QUS:AU BetaShares S&P 500 Equal .. 0.89 % 0.00 %

N/A

USD 0.35B
QEH 0.00 % 1.68 %

N/A

N/A
EQL:CA Invesco S&P 500 Equal Wei.. 0.00 % 0.26 %

-0.04 (0%)

CAD 0.85B
EQL-F:CA Invesco S&P 500 Equal Wei.. 0.00 % 0.00 %

N/A

N/A
EQL-U:CA Invesco S&P 500 Equal Wei.. 0.00 % 0.00 %

-0.03 (0%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.97% 79% B- 70% C-
Dividend Return 1.06% 49% F 33% F
Total Return 21.03% 79% B- 68% D+
Trailing 12 Months  
Capital Gain 5.17% 75% C 69% C-
Dividend Return 1.40% 37% F 26% F
Total Return 6.56% 71% C- 63% D
Trailing 5 Years  
Capital Gain 43.05% 82% B 78% C+
Dividend Return 8.83% 44% F 32% F
Total Return 51.88% 81% B- 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 7.09% 55% F 60% D-
Dividend Return 8.66% 49% F 59% D-
Total Return 1.56% 52% F 41% F
Risk Return Profile  
Volatility (Standard Deviation) 8.90% 36% F 88% B+
Risk Adjusted Return 97.30% 51% F 92% A
Market Capitalization 10.83B 97% N/A 89% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.